Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Sub: Publishing of Financial Results in Newspaper Ref: Regulation 47(1)(b) of SEBI (Listing Obligations & Disclosures Requirements) Regulations, 2015 Further to our intimation dated 3rd November, 2020, please find the enclosed herewith copies of the newspaper advertisements published on 5th November, 2020, regarding financial results for quarter and half year ended as on 30th September, 2020. Please that this information is published within 48 hours of closure of the Board Meeting as specified in Regulation 47(3) of SEBI (Listing obligations & Disclosure Requirements) regulations, 2015.
05-11-2020
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Outcome Of Board Meeting Held On 3Rd November, 2020

 With reference to the above subject, we would like to inform you that Board of Directors of the Company at their meeting held today, inter-alia considered and approved the following: 1. The Standalone and consolidated Un-audited Financial Results for the Quarter and half year ended 30th September, 2020 along with the Limited Review Report Accordingly, please find the enclosed the following:- 1. Standalone and Consolidated un-audited Financial Results for the quarter and half year ended 30th September, 2020 along with the Limited Review Report. Please take the above intimation on your records.
03-11-2020
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Advertisement In News Paper.

 With reference to subject cited above we are herewith enclosing the copies of advertisement issued in newspapers on 29th October, 2020 in 'Financial Express' in English language and in 'Andhra Prabha' in Telugu Language, with respect to intimation of Board Meeting for considering Un-audited financial results for the quarter and half year ended 30th September, 2020.
29-10-2020
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Board Meeting Intimation for Notice Of Board Meeting To Be Held On 03.11.2020

 SMS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2020 ,inter alia, to consider and approve NOTICE is hereby given pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Sec. 173 of the Companies Act, 2013 that a meeting of the Board of Directors of the Company will be held on the Tuesday, 03rd day of November, 2020, at the Registered Office of the Company, inter alia, for the following items: To consider and approve the Un-audited Standalone and Consolidated Financial results of the Company for the Quarter and half year ended as on 30th September, 2020. Please be informed that Insider Trading window of SMS Pharmaceuticals Limited shall remain closed till 5th November, 2020 in view of the above mentioned Board Meeting.
27-10-2020
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Statement Under Regulation 40(9)&(10) For The Half Year Ended On 30Th September, 2020

 Pursuant to the Regulation 40(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are submitting herewith a Compliance certificate issued by Mr. C. Sudhir Babu, practicing company secretary for the half year ended 30th September, 2020.
19-10-2020
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - COMPLIANCE CERTIFICATE UNDER REGULATION 7(3) OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS)REGULATIONS, 2015 FOR THE HALF YEAR ENDED 30Th SEPTEMBER, 2020

 1. We the undersigned, hereby certify that all activities pertaining to transfer of equity shares both in physical and electronic form of the SMS Pharmaceuticals Limited for the period from 1st April, 2020 to 30th September, 2020 has been maintained by the Registrar & Share Transfer Agent (RTA & STA) M/s. AARTHI CONSULTANTS PRIVATE LIMITED (SEBI registration number INR000000379), having office at 1-2-285, Domalguda, Hyderabad, Telangana-500029 in effective and efficient manner. 2. This Certificate is issued in pursuance of Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and should not be used for any other purpose.
15-10-2020
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 we are forwarding herewith a copy of the Certificate dated 13th October, 2020, received from Aarthi Consultants Private Limited, Hyderabad, the Registrar and Share Transfer Agent of the Company for the quarter ended 30th September, 2020.
14-10-2020
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Statement Of Investor Complaints For The Quarter Ended September 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- V S VenkatishDesignation :- Company Secretary and Compliance Officer
14-10-2020
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Shareholding for the Period Ended September 30, 2020

 SMS Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here
13-10-2020
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 SMS Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
03-10-2020
Next Page
Close

Let's Open Free Demat Account